Showing results (501-510 of 536) with videos related to
Sort By:
Pageof 54
Iscience|March 21, 2022
Aberrant newborn T cell and microbiota developmental trajectories predict respiratory compromise during infancyAndrew McDavid, Nathan Laniewski, Alex Grier, et al.Journal of the American Society for Mass Spectrometry|September 26, 2023
Expanding Per- and Polyfluoroalkyl Substances Coverage in Nontargeted Analysis Using Data-Independent Analysis and IonDeconJeremy P Koelmel, Michael Kummer, Olivier Chevallier, et al.Nature Methods|April 20, 2023
Engineering of NEMO as calcium indicators with large dynamics and high sensitivityJia Li, Ziwei Shang, Jia-Hui Chen, et al.Proceedings of the National Academy of Sciences of the United States of America|April 20, 2021
People have shaped most of terrestrial nature for at least 12,000 yearsErle C Ellis, Nicolas Gauthier, Kees Klein Goldewijk, et al.Journal of Neurotrauma|November 16, 2018
Electrophysiological Guidance of Epidural Electrode Array Implantation over the Human Lumbosacral Spinal Cord to Enable Motor Function after Chronic ParalysisJonathan S Calvert, Peter J Grahn, Jeffrey A Strommen, et al.Nature|February 8, 2022
Automated iterative Csp<sup>3</sup>-C bond formationDaniel J Blair, Sriyankari Chitti, Melanie Trobe, et al.Nature Medicine|October 25, 2018
Publisher Correction: Neuromodulation of lumbosacral spinal networks enables independent stepping after complete paraplegiaMegan L Gill, Peter J Grahn, Jonathan S Calvert, et al.Journal of Medicinal Chemistry|January 22, 2005
Identification of novel p38alpha MAP kinase inhibitors using fragment-based lead generationAdrian L Gill, Martyn Frederickson, Anne Cleasby, et al.Nature Medicine|September 26, 2018
Neuromodulation of lumbosacral spinal networks enables independent stepping after complete paraplegiaMegan L Gill, Peter J Grahn, Jonathan S Calvert, et al.Journal of Medicinal Chemistry|March 8, 2025
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted CancersJames Cregg, Anne V Edwards, Stephanie Chang, et al.Pageof 54